Spyre Therapeutics to Participate in the Jefferies Global Healthcare Conference Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the Company or Spyre ), a development-stage biotechnology company advancing best-in-class antibody...
Wednesday, May 29, 2024 BiopharmaWatch Research 1 min read
Key Takeaway: Spyre Therapeutics, a development-stage biotechnology company, is set to participate in the Jefferies Global Healthcare Conference. This involvement aims to enhance its visibility in the healthcare sector and showcase its advancements in antibody therapies. Following the conference, a webcast will be available for replay for 90 days, providing further accessibility to interested stakeholders.
Price reaction · baseline $33.09 (2024-05-28 close) · hit after-hours · 1 other SYRE headline(s) in the window, move may be shared
day 0 close · peak
-3.1%
Market Sentiment Analysis
POSITIVE FACTORS
Spyre Therapeutics is advancing best-in-class antibody therapies.
Participation in the Jefferies Global Healthcare Conference highlights company visibility.
The webcast will be available for replay, increasing engagement.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+249%
120-day peak, hindsight
Typical move
3.2%
average across 3 past catalysts
Cash runway
~49 mo
Minimal dilution risk
Lead asset
Co-ArgI-PEG modified human arginase I
Phase 2 · Acute Myeloid Leukemia
Full Press Release Details
To access this webcast, please visit the "Events & Presentations" page within the Investors section of the Spyre website at ir.spyre.com. An archive of the webcast will be available for replay for 90 days following the end of the conference.
About Spyre Therapeutics
Follow Spyre Therapeutics on social media: @spyretx and LinkedIn
Frequently Asked Questions
How can I access the Spyre webcast?
Visit the 'Events & Presentations' page in the Investors section at ir.spyre.com.
How long will the webcast be available for replay?
The webcast archive will be available for replay for 90 days after the conference.
Where can I find Spyre Therapeutics on social media?
Follow Spyre Therapeutics on Twitter @spyretx and LinkedIn.